Print this page
-
A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor.
Protocol: 112104Principal Investigator:
- Scott Moerdler M.D. (Rutgers University)
Applicable Disease Sites: Brain and Nervous System -
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT).
Protocol: 112106Principal Investigator:
- Scott Moerdler M.D. (Rutgers University)
Applicable Disease Sites: Kidney -
Community Engagement in Developing a Web-Based Single-Session Psychosocial Intervention for Adolescent Siblings of Youth with Cancer
Protocol: 132302Principal Investigator:
- Christina Amaro PhD (Rutgers Cancer Institute of New Jersey)
Applicable Disease Sites: Other -
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol.
Protocol: 111706Principal Investigator:
- Richard Drachtman M.D. (Rutgers University)
Applicable Disease Sites: Any Site -
Pediatric Acute Leukemia (PedAL) Screening Trial: Developing New Therapies for Relapsed Leukemias.
Protocol: 112204Principal Investigator:
- Richard Drachtman M.D. (Rutgers University)
Applicable Disease Sites: Leukemia, not otherwise specified -
A bilingual virtually-based intervention (PEDALL) for the prevention of weight gain in childhood ALL patients considering key genetic and sociodemographic risk factors
Protocol: 112307Principal Investigator:
- Peter Cole M.D. (Rutgers University)
Applicable Disease Sites: Other